All Categories
FDA approves first AI test to guide breast cancer...
As of 2022, there were about 2.3 millionTrusted Source women around the world newly diagnosed with breast cancer, and about 6 [...]
ArteraAI Offers a New Approach to Breast Cancer Treatment...
Matthew Kurian, MD, examines ArteraAI Breast, a newly FDA-cleared multimodal platform that combines pathology imaging and cli [...]
Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announ [...]
For Women Over 50, AI Could Change Breast Cancer...
For women over 50, a breast cancer diagnosis often comes with a difficult and deeply personal question: Do you really need ch [...]
He Was Told He Needed Surgery for Cancer: A...
When Howard Wolinsky went in for a routine checkup in his mid-50s. He thought he was doing everything right. “I was just bein [...]
CHHiP Trial Evaluates a Multimodal AI Biomarker in Localized...
Anna Wilkins describes her validation of the Artera MMAI biomarker, drawing on over 2,000 biopsies from the 3,200-patient CHH [...]
ASCO to shine light on multimodal AI models: Plus,...
Dr. Lu will highlight recent work using specimens from the NRG B-20 trial, in which investigators applied multimodal AI appro [...]
Artera Secures CE Marking for Its AI Prostate and...
Dual regulatory milestones establish Artera as a global AI leader in precision oncology SAN FRANCISCO, April 21, 2026— Artera [...]